Table:
begin	end	state
1	20	cytoplasmic
21	39	transmembrane
40	52	non-cytoplasmic
53	72	transmembrane
73	77	cytoplasmic
78	96	transmembrane
97	101	non-cytoplasmic
102	121	transmembrane
122	145	cytoplasmic
146	165	transmembrane
166	172	non-cytoplasmic
173	194	transmembrane
195	200	cytoplasmic
201	217	transmembrane
218	222	non-cytoplasmic
223	247	transmembrane
248	253	cytoplasmic
254	274	transmembrane
275	320	non-cytoplasmic
321	340	transmembrane
341	373	cytoplasmic
374	393	transmembrane
394	408	non-cytoplasmic
409	434	transmembrane
435	445	cytoplasmic
446	462	transmembrane
463	505	non-cytoplasmic

Input:
>AZOBR_RS08240 FitnessBrowser__azobra:AZOBR_RS08240
MTAISMSSPRAIAWPSILKEAAMTAFVALLLTIPLVGLRTVDRPTGLGLETRWNEVAAAV
GLVFLGRLGLCLIREGHAVTVLVLAAAATAAGFFIAMPTEALRVILIAGGAVIAIRAVLA
IRTGRSKLSQAERDKRMDHIAAQVQHASRWLGPIAVVVALAFPFTPLADRQLLDIGILLL
TYIMLGWGLNIVVGLAGLLDLGYVAFYAVGAYSYALLAHYFGFSFWVCLPLAGFLAAMSG
VLLGFPVLRLRGDYFAIVTLGFGEIIRIILINWYQFTGGPNGISGIPRPSFFGIADFTRT
PAEGTAAFHEMFGLEFSPLHRIIFLYYLILVLALVVNLFTMRVRKLPLGRAWEALREDDI
ACASLGINRTNMKLAAFAIAAMFGGFAGSFFATRQGFISPESFTFIESAIILAIVVLGGM
GSQIGVVVAAFLVIGLPEAFRELADYRMLAFGMGMVLIMLWRPRGLLAHRDPTILLHGRP
KGGAGGPAAGSAAAGGQGIAGGSAK

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server